Rösch W
Medizinischen Klinik, Frankfurt am Main.
Wien Med Wochenschr. 1988 Jun 30;138(11-12):278-81.
Among the risk conditions with an increased prevalence or incidence of colorectal carcinomas hereditary and acquired disorders have to be differentiated. While in hereditary forms new in vitro tests may play a role in the identification of patients at risk we have to rely on screening and follow-up programmes in the other group of patients. The intervals of these surveillance programmes should be acceptable to the patient since many risk groups seem to be questionable on a cost-benefit evaluation.
在结直肠癌患病率或发病率增加的风险状况中，必须区分遗传性疾病和后天性疾病。对于遗传性疾病，新的体外检测可能在识别高危患者方面发挥作用，而对于另一组患者，我们必须依靠筛查和随访计划。这些监测计划的间隔时间应该为患者所接受，因为从成本效益评估来看，许多风险组似乎存在问题。
